Population pharmacokinetics and effects of indinavir in HIV infected patients.

被引：0
|
作者：
Csajka, C
Marzolini, C
Fattinger, K
Decosterd, LA
Telenti, A
Biollaz, J
Buclin, T
机构：
[1] Univ Lausanne Hosp, Lausanne, Switzerland
[2] Univ Zurich Hosp, CH-8091 Zurich, Switzerland
[3] Univ Lausanne, Lausanne, Switzerland
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2003年 / 73卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(03)90613-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P69 / P69
页数：1
相关论文
共 50 条
  • [31] POPULATION PHARMACOKINETICS OF PROTHIONAMIDE IN KOREAN PATIENTS.
    Seong, S.
    Lee, J.
    Park, S.
    Lim, M.
    Park, J.
    Seo, J.
    Lee, H.
    Yoon, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S87 - S87
  • [32] Population pharmacokinetics of pixantrone in cancer patients.
    Bernareggi, A
    Allievil, C
    Hussein, Z
    Pitsiu, M
    Nell, HAB
    Aarons, L
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6247S - 6247S
  • [33] Membranous nephropathy in HIV infected patients.
    Wei, A
    Williams, BA
    Burns, GC
    Brand, DA
    Patrick, PA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 382A - 382A
  • [34] Indinavir-ritonavir combination:: pharmacokinetics and tolerance in patients with HIV infection
    Bani-Sadr, F
    Perré, P
    Peytavin, G
    Bernard, L
    Melchior, JC
    Perronne, C
    de Truchis, P
    PRESSE MEDICALE, 2001, 30 (15): : 731 - 735
  • [35] Intestinal absorption in HIV infected patients.
    Mouly, S
    Bergmann, JF
    Halimi, C
    Caulin, C
    GASTROENTEROLOGY, 1996, 110 (04) : A974 - A974
  • [36] Renal abnormalities in HIV infected patients.
    Marta Pernasetti, Maria
    Chiurchiu, Carlos
    de la Puente, Jorge
    De Arteaga, Javier
    Douthat, Walter
    Bardosy, Cecilia
    Zarate, Abel
    Massari, Pablo U.
    MEDICINA-BUENOS AIRES, 2010, 70 (03) : 247 - 253
  • [37] Nutritional disorders in HIV infected patients.
    Rabaud, C
    Maignan, M
    Amiel, C
    Alfandari, S
    May, T
    Canton, P
    REVUE DE MEDECINE INTERNE, 1996, 17 (12): : 992 - 1002
  • [38] Indinavir (Crixivan®) urolithiasis in HIV-positive patients.: Treatment and prophylaxis
    Kalaitzis, C
    Touloupidis, S
    Patris, E
    Lehrich, K
    Kuntz, RM
    UROLOGE A, 2004, 43 (02): : 168 - 171
  • [39] Effect of fluconazole on indinavir pharmacokinetics in human immunodeficiency virus-infected patients
    De Wit, S
    Debier, M
    De Smet, M
    McCrea, J
    Stone, J
    Carides, A
    Matthews, C
    Deutsch, P
    Clumeck, N
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (02) : 223 - 227
  • [40] Population pharmacokinetics of dolutegravir in HIV-infected treatment-naive patients
    Zhang, Jianping
    Hayes, Siobhan
    Sadler, Brian M.
    Minto, Ilisse
    Brandt, Julie
    Piscitelli, Steve
    Min, Sherene
    Song, Ivy H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (03) : 502 - 514
12345